Advertisement

Topics

#news #biotech Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO

08:08 EDT 10 Aug 2017 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO .Celgene and Sutro Biopharma have revised the terms of … Continue reading

Cet article #news #biotech Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO est apparu en premier sur Biotech 365.

Original Article: #news #biotech Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...